+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

New-onset heart failure due to heart muscle disease in childhood: a prospective study in the United kingdom and Ireland



New-onset heart failure due to heart muscle disease in childhood: a prospective study in the United kingdom and Ireland



Circulation 117(1): 79-84



We undertook the first prospective, national, multicenter study to describe the incidence and outcome of heart muscle disease-induced heart failure in children. Data were collected on patients admitted to a hospital through 2003 with a first episode of heart failure in the absence of congenital heart disease. All 17 pediatric cardiac centers in the United Kingdom and Ireland participated. Follow-up data were obtained to a minimum of 1 year. The incidence was 0.87/100,000 population <16 years (n=104; 53 girls; 95% confidence interval 0.71 to 1.05 per 100,000). Median age at presentation was 1 year, with 82% in New York Heart Association class III to IV. Causes of heart failure included dilated cardiomyopathy (50 idiopathic, 8 familial), probable myocarditis (23), occult arrhythmia (7), anthracycline toxicity (5), metabolic disease (4), left ventricular noncompaction (3), and other (4). Overall 1-year survival was 82%, and event (death or transplantation)-free survival was 66%. Regression analysis showed older age and reduced systolic function on admission echocardiogram increased the event risk. Only 8% of event-free survivors (n=69) remained in New York Heart Association class III to IV, but 35 required readmission during the study period, and all but 8 remained on medication. This first national prospective study of new-onset heart failure in children has shown an incidence of 0.87/100,000. Multivariable analysis of survival data indicates a better outcome for younger children and for those with better systolic function at presentation, but overall, one third of children die or require transplantation within 1 year of presentation.

(PDF emailed within 0-6 h: $19.90)

Accession: 021422778

Download citation: RISBibTeXText

PMID: 18086928

DOI: 10.1161/circulationaha.106.671735


Related references

Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 98(15): 1510-1516, 1998

Heart failure from heart muscle disease in childhood: a 5-10 year follow-up study in the UK and Ireland. Esc Heart Failure 3(2): 107-114, 2016

The relationship between QT intervals and mortality in ambulant patients with chronic heart failure. The united kingdom heart failure evaluation and assessment of risk trial (UK-HEART). European Heart Journal 20(18): 1335-1341, 1999

Pace of change in coronary heart disease mortality in Finland, Ireland and the United Kingdom from 1985 to 2006. European Journal of Public Health 18(6): 581-585, 2008

Prognosis for South Asian and white patients with heart failure in the United Kingdom: counterintuitive findings on heart failure in South Asians may be artefactual. BMJ 327(7428): 1405-6, 1406, 2003

Prospective, national clinical and epidemiologic study on imported childhood malaria in the United Kingdom and the Republic of Ireland. Pediatric Infectious Disease Journal 29(5): 434-438, 2010

Coronary heart disease and risk factors in NIDDM. Experience from the United Kingdom Prospective Diabetes Study. Diabetologia 40(SUPPL. 2): S121-S122, 1997

Depression and ischemic heart disease mortality: evidence from the EPIC-Norfolk United Kingdom prospective cohort study. American Journal of Psychiatry 165(4): 515-523, 2008

How well can we predict coronary heart disease? Findings in the United Kingdom Heart Disease Prevention Project. British Medical Journal 288(6428): 1409-1411, 1984

Changes in body composition with danazol therapy**Supported in part by Sterling Winthrop Laboratories, Guildford, United Kingdom, and by the Heart Disease and Diabetes Research Trust, London, United Kingdom. Fertility and Sterility 56(3): 574-576, 1991

Free protein S level as a risk factor for coronary heart disease and stroke in a prospective cohort study of healthy United Kingdom men. American Journal of Epidemiology 174(8): 958-968, 2011

The falling mortality from coronary heart disease: a clinicopathological perspective. The United Kingdom Heart Attack Study (UKHAS) Collaborative Group. Heart 80(2): 121-126, 1998

Estimating coronary heart disease risk using the United Kingdom Prospective Diabetes Study Risk Engine. Diabetes 52(Supplement 1): A151, 2003

Prevalence of vaccination rates in systolic heart failure: a prospective study of 549 patients by age, race, ethnicity, and sex in a heart failure disease management program. Congestive Heart Failure 16(6): 278-283, 2011

Relationship between history of coronary heart disease at dialysis initiation and onset of events associated with heart disease: a propensity-matched analysis of a prospective cohort study. Bmc Nephrology 18(1): 79, 2018